{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fcomy-protein-degradation-modulators-6URymiHS","width":444,"version":"1.0","type":"rich","title":"Recent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Care Of Patients With Myeloma","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/8a3ef71e-c1e3-4f3b-b0b5-a410a27e3a46/101685_mm_celmod_ss_comy3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/76539245-3578-4f60-9dbe-521809c0e9ba\" height=\"200\" width=\"100%\" title=\"Recent Advances, Future Directions, and Ideas on Integrating CELMoDs Into The Care Of Patients With Myeloma\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to this podcast to hear Sagar Lonial, MD, FACP, FASCO, and Mohamad Mohty, MD, PhD, discuss recent advances, future directions, and the integration of novel protein degradation modulator-based therapy into myeloma care, including what clinicians may expect when incorporating these therapies into practice."}